LUMN · Lumen Technologies, Inc.

The price in column 4 is a weighted average price. The prices actually paid for the stock ranged from $6.065 to $6.175 per share. The Reporting Person has provided the Company, and upon request, will provide any security holder of the Company or the staff of the U.S. Securities and Exchange Commission, with information regarding the number of shares acquired at each price within that range.

Shares are held by the Revocable Trust of Todd and Kathleen Johnson, u/a/d November 29, 2021, of which the Reporting Person is a trustee.

This grant of restricted stock units will vest on August 5, 2027, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.

This grant of restricted stock units will vest on May 21, 2027, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.

This grant of restricted stock units will vest on May 21, 2027, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.

This grant of restricted stock units will vest on May 21, 2027, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.

This grant of restricted stock will vest on May 21, 2027.

This grant of restricted stock units will vest on May 21, 2027, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.

This grant of restricted stock units will vest on May 21, 2027, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.

This grant of restricted stock will vest on May 21, 2027.

This grant of restricted stock will vest on May 21, 2027.

Shares withheld to cover the taxes due upon the vesting of equity awards.

Represents the reporting person's transfer of 241,450 shares of the Issuer's common stock for estate planning purposes to an irrevocable trust for the benefit of her spouse and children.

Represents the reporting person's transfer of 241,450 shares of the Issuer's common stock for estate planning purposes to an irrevocable trust for the benefit of her spouse and children.

The reporting person disclaims ownership of the shares held in this trust, except to the extent of her beneficial ownership therein.

Represents a grant of restricted stock (40% time-based and 60% performance-based). The time-based portion will vest in three equal annual installments on April 20, 2027, March 1, 2028, and March 1, 2029. Vesting of the performance-based portion is dependent upon the extent to which two three-year performance metrics are achieved, with any earned shares vesting on March 1, 2029.

Shares withheld to cover the taxes due upon the vesting of equity awards.

Represents a grant of restricted stock (40% time-based and 60% performance-based). The time-based portion will vest in three equal annual installments beginning on March 1, 2027. Vesting of the performance-based portion is dependent upon the extent to which two three-year performance metrics are achieved, with any earned shares vesting on March 1, 2029.

Represents a grant of restricted stock (40% time-based and 60% performance-based). The time-based portion will vest in three equal annual installments beginning on March 1, 2027. Vesting of the performance-based portion is dependent upon the extent to which two three-year performance metrics are achieved, with any earned shares vesting on March 1, 2029.

Represents performance-based restricted shares or RSUs granted on May 18, 2023, which reflects the net amount after a portion were forfeited on March 1, 2026, for failing to achieve the three-year performance metrics and a portion were determined to exceed the applicable performance target.

Shares withheld to cover the taxes due upon the vesting of equity awards.

Represents a grant of restricted stock (40% time-based and 60% performance-based). The time-based portion will vest in three equal annual installments beginning on March 1, 2027. Vesting of the performance-based portion is dependent upon the extent to which two three-year performance metrics are achieved, with any earned shares vesting on March 1, 2029.

Shares withheld to cover the taxes due upon the vesting of equity awards.

Represents a grant of restricted stock (40% time-based and 60% performance-based). The time-based portion will vest in three equal annual installments beginning on March 1, 2027. Vesting of the performance-based portion is dependent upon the extent to which two three-year performance metrics are achieved, with any earned shares vesting on March 1, 2029.

Represents a grant of restricted stock (40% time-based and 60% performance-based). The time-based portion will vest in three equal annual installments beginning on March 1, 2027. Vesting of the performance-based portion is dependent upon the extent to which two three-year performance metrics are achieved, with any earned shares vesting on March 1, 2029.

Represents a grant of restricted stock (40% time-based and 60% performance-based). The time-based portion will vest in three equal annual installments beginning on March 1, 2027. Vesting of the performance-based portion is dependent upon the extent to which two three-year performance metrics are achieved, with any earned shares vesting on March 1, 2029.

Represents performance-based restricted shares or RSUs granted on May 18, 2023, which reflects the net amount after a portion were forfeited on March 1, 2026, for failing to achieve the three-year performance metrics and a portion were determined to exceed the applicable performance target.

Ms. Linear sold common shares in connection with tax and estate planning activities.

The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $7.89 - $7.91. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

The price in column 4 is a weighted average price. The prices actually paid for the stock ranged from $6.2775 to $6.42 per share. The reporting person has provided the Company, and upon request, will provide any security holder of the Company or the SEC staff, with information regarding the number of shares acquired at each price within that range.

Represents a sign-on equity grant of time-based restricted stock. 288,141 shares will vest in three equal annual installments beginning on February 4, 2027. The remaining 288,141 will vest in equal installments on February 4, 2027 and February 4, 2028.

Shares withheld to cover the taxes due upon the vesting of equity awards.

Represents a sign-on equity grant of time-based restricted stock. 487,787 shares will vest in three equal annual installments beginning on January 5, 2027. The remaining 125,073 will vest in equal installments on January 5, 2031 and January 5, 2033.

Shares withheld to cover the taxes due upon the vesting of equity awards.

Represents a grant of restricted stock vesting in three equal annual installments beginning on September 23, 2026.

The price in column 4 is a weighted average price. The prices actually paid for the stock ranged from $4.38 to $4.53 per share. The reporting person has provided the Company, and upon request, will provide any security holder of the Company or the SEC staff, with information regarding the number of shares acquired at each price within that range.

The ARS Trust, a revocable trust for the benefit of the reporting person's spouse, was previously described as the AMR Trust on the reporting person's Forms 4.

The price in column 4 is a weighted average price. The prices actually paid for the stock ranged from $4.38 to $4.53 per share. The reporting person has provided the Company, and upon request, will provide any security holder of the Company or the SEC staff, with information regarding the number of shares acquired at each price within that range.

The RJR Trust is an irrevocable trust for the benefit of the reporting person's child.

The price in column 4 is a weighted average price. The prices actually paid for the stock ranged from $4.38 to $4.53 per share. The reporting person has provided the Company, and upon request, will provide any security holder of the Company or the SEC staff, with information regarding the number of shares acquired at each price within that range.

The SSR DSNT is an irrevocable trust for the benefit of the reporting person's child.

The price in column 4 is a weighted average price. The prices actually paid for the stock ranged from $4.205 to $4.33 per share. The reporting person has provided the Company, and upon request, will provide any security holder of the Company or the SEC staff, with information regarding the number of shares acquired at each price within that range.

The RJR Trust is an irrevocable trust for the benefit of the reporting person's child.

Represents the reporting person's transfer of 1,086,315 shares of the Issuer's common stock for estate planning purposes to an irrevocable trust for the benefit of her spouse and children.

The reporting person disclaims ownership of the shares held in this trust, except to the extent of her beneficial ownership therein.

Represents the reporting person's transfer of 1,086,315 shares of the Issuer's common stock for estate planning purposes to an irrevocable trust for the benefit of her spouse and children.

The price in column 4 is a weighted average price. The prices actually paid for the stock ranged from $4.205 to $4.33 per share. The reporting person has provided the Company, and upon request, will provide any security holder of the Company or the SEC staff, with information regarding the number of shares acquired at each price within that range.

The SSR DSNT is an irrevocable trust for the benefit of the reporting person's child.

The price in column 4 is a weighted average price. The prices actually paid for the stock ranged from $4.205 to $4.33 per share. The reporting person has provided the Company, and upon request, will provide any security holder of the Company or the SEC staff, with information regarding the number of shares acquired at each price within that range.

The ARS Trust, a revocable trust for the benefit of the reporting person's spouse, was previously described as the AMR Trust on the reporting person's Forms 4.

The price in column 4 is a weighted average price. The prices actually paid for the stock ranged from $3.693132 to $3.695 per share. The reporting person has provided the Company, and upon request, will provide any security holder of the Company or the SEC staff, with information regarding the number of shares acquired at each price within that range.

This grant of restricted stock units will vest on May 14, 2026, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.

This grant of restricted stock will vest on May 14, 2026.

This grant of restricted stock units will vest on May 14, 2026, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.

This grant of restricted stock units will vest on May 14, 2026, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.

This grant of restricted stock will vest on May 14, 2026.

This grant of restricted stock units will vest on May 14, 2026, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.

This grant of restricted stock units will vest on May 14, 2026, but will be paid out in shares of Common Stock at a later date according to the Reporting Person's deferral election.

This grant of restricted stock will vest on May 14, 2026.